ZB-011

N/A

Report date: 2024/02/21 14:30:15

Base Information

Drug NameZB-011
Drug Alias NameZB-011ZB011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Insulin-like growth factor I receptor
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsGraves Ophthalmopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMacauHong Kong +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesViridian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZenas BioPharma Inc
Inactive CompaniesN/A
Active IndicationsGraves Ophthalmopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A